Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Eli Lilly Warns Against ‘Cosmetic’ Use of Popular Weight-Loss Drugs

“Mounjaro and Zepbound are indicated for the treatment of serious diseases; they are not approved for – and should not be used for – cosmetic weight loss,” the company said in a statement Thursday morning.
Famed for speedy weight loss, Ozempic is having far-reaching consequences.
Eli Lilly & Co. cautioned against using its popular diabetes and obesity drugs for “cosmetic weight loss." (Shutterstock)

Eli Lilly & Co. cautioned against using its popular diabetes and obesity drugs for “cosmetic weight loss” as off-label use of the medications has skyrocketed and shortages ensued.

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

In This Article

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.
view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.
VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON